ArticleOncoTargets and therapy2021

Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review.

Rumeng Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.